PolyPid Ltd. (PYPD) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for PolyPid Ltd. in 2026. The next earnings report is expected on November 11, 2026.
Next earnings date
11 Nov 2026
In 84 days
EPS estimate
-0.39
Revenue estimate
0
Past earnings
Latest earnings analysis
PolyPid Ltd. beat consensus on EPS and met revenue expectations, with EPS of USD -0.35 versus an estimate of USD -0.3775 and revenue of USD 0 matching estimates. In the prior quarter, EPS also came in ahead of expectations while revenue again met estimates.
No dividend history available.
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
PolyPid Ltd. (PYPD) is scheduled to report earnings on November 11, 2026.
PolyPid Ltd. (PYPD) last reported earnings on August 12, 2026.
PolyPid Ltd. (PYPD) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.